Surgical rehabilitation of swallowing with polydimethylsiloxane injections after open partial horizontal laryngectomy: Long-term functional results and quality of life

Complications of Polydimethylsiloxane for Injection Laryngoplasty: Retrospective Case Series of 10 Patients Requiring Explant and Literature Review

Polydimethylsiloxane (PDMS) has been reported in the literature as a safe and permanent material for injection laryngoplasty (IL)1 We present a case series of 10 patients who had undergone PDMS-IL at external campuses which resulted in unsatisfactory voice outcomes and were managed with explant. A literature review on PDMS-IL associated complications is presented. In our series, seven out of ten patients (70%) with voice outcomes data, developed an improved voice post PDMS explant. Seven out of ten patients (70%) had improved vocal fold pliability with two patients (20%) having irretrievably damaged pliability due to the PDMS disturbing the superficial lamina propria. All eight patients with specimens submitted for histopathology had foreign body inflammation reported. There were ten additional cases reported in the literature with post PDMS adverse outcomes managed with explant. In the literature, explant improved the voice in seven out of nine patients (78%) with reported voice outcomes and partially restored vocal fold pliability in five out of six patients (83%) which commented on this outcome. PDMS-IL carries a risk of irreversible loss of vocal fold pliability which should be informed to the patient as part of the preoperative informed consent.

Phonosurgical Injection Approaches for Voice Restoration After Open Partial Horizontal Laryngectomies: A Pilot Study

OBJECTIVE

The aim of the present study is to evaluate the efficacy of phonosurgical corrective approaches based on injection laryngoplasties and pharyngoplasties followed by speech therapy for voice restoration after unsatisfactory phonatory results of open partial horizontal laryngectomies.

METHODS

Ten patients with not satisfying phonatory results despite speech therapy after type II or type III open partial horizontal laryngectomies (OPHLs) were included. Each patient underwent a voice restoration program based on phonosurgery (injection laryngoplasty and/or injection pharyngoplasty) with hyaluronic acid and/or calcium hydroxyapatite, followed by post-surgical voice rehabilitation. Voices were recorded and analysed through spectrographic, aerodynamic, perceptual, laryngoscopic and self-assessment evaluations before the treatment (T0), after 1 month (T1) and after three months (T2).

RESULTS

Significant improvements in the patients voices were found between T0, T1 and T2 concerning acoustic, perceptual, aerodynamic, laryngoscopic and self assessment evaluations.

CONCLUSIONS

The results of the present study support phonosurgical injection procedures followed by speech therapy as an effective strategy for voice restoration after type II or type III OPHLs in selected patients.